Courtney L. Scaife,
MD
Vice-Chair for Cancer Affairs in Surgery, Department of Surgery; Chief, Section of Surgical Oncology, Division of General Surgery
Languages Spoken: English
Dr. Courtney Scaife is a Professor of Surgery at the University of Utah who specializes in the care of patients requiring surgical treatment related to gastrointestinal oncology. Dr. Scaife earned her undergraduate degree from DePauw University and medical degree from the University of Wisconsin. Her general surgery residency was done at the University of Utah which was followed by a two-year fellowship in surgical oncology at the University of Texas MD Anderson Cancer Center. Dr. Scaife joined the faculty at the University of Utah in 2003 and is a tenured academic surgeon. Dr. Scaife’s focus in surgery involves diseases of the liver, pancreas, and gastrointestinal tract. Her clinical efforts include both complex surgical endeavors as well as academic research. She has received numerous research grants and participates with other colleagues in the areas of diagnosis and treatment of cancer, in particular pancreatic cancer.
Dr. Scaife was appointed as the Vice-Chair for Cancer Affairs in Surgery representing the Department of Surgery at the Huntsman Cancer Institute. She is the Chief for the Section of Surgical Oncology in the Division of General Surgery. Additionally, she serves as the Gastrointestinal Disease Center Leader at the Huntsman Cancer Institute.
Clinical Locations
Clinic 2B, GI Oncology
801-585-0250
Fax: (801) 585-3846
Specialties
- Liver, Biliary, & Pancreas Surgery
- Colorectal Surgery
- Esophageal Surgery
- Gastric/Esophageal Surgery
- Oncology Surgery
- Soft Tissue Sarcoma Surgery
- Minimally Invasive Gastrointestinal Surgery
- Sarcoma
- Surgery, General
- Gastrointestinal Stromal Tumors
- Upper Gastrointestinal Tract Surgery
- Pancreatic Cancer
Board Certification and Academic Information
| Academic Departments | Surgery
-
Professor |
| Academic Divisions | General Surgery |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.9/ 5
Care provider's explanation of condition/problem
4.8/ 5
Care provider's effort to include me in decisions
4.8/ 5
Wait time at clinic
4.6/ 5
Care provider's concern for questions & worries
4.8/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
November 22, 2022
Huntsman Cancer Institute
She was wonderful and very caring.
UofU Patient
November 21, 2022
Huntsman Cancer Institute
Your hospital is a well oiled machine and I gives me a great deal of confidence.
UofU Patient
November 20, 2022
Huntsman Cancer Institute
1st time I've ever done this, very easy
UofU Patient
November 20, 2022
Huntsman Cancer Institute
Very caring. Explained everything clearly and took the time to answer all questions. Excellent experience.
UofU Patient
November 17, 2022
Huntsman Cancer Institute
They were great
UofU Patient
November 07, 2022
Huntsman Cancer Institute
Enjoyed talking with her
UofU Patient
November 06, 2022
Huntsman Cancer Institute
Physician assistant Brown was doing well until Dr. Scaife arrived.
UofU Patient
October 16, 2022
HUNTSMAN CANCER CENTER
Great service.
UofU Patient
October 09, 2022
HUNTSMAN CANCER CENTER
Very good experience
UofU Patient
October 02, 2022
HUNTSMAN CANCER CENTER
Absolutely, would recommend her to anyone needing cancer surgery.
UofU Patient
September 25, 2022
HUNTSMAN CANCER CENTER
As I expected, Dr. Scaife was superior. She was patient, informative, kind, and detailed. She inspired confidence and left my family and I knowing we were in expert hands.
UofU Patient
September 18, 2022
HUNTSMAN CANCER CENTER
All Good
UofU Patient
September 09, 2022
HUNTSMAN CANCER CENTER
Needed advice to start stool softener and laxatives immediately after surgery.
UofU Patient
August 09, 2022
HUNTSMAN CANCER CENTER
Dr. Courtney Scaife is so great she addresses all of my concerns never acts like she's in a hurry
UofU Patient
August 03, 2022
HUNTSMAN CANCER CENTER
Recommendation of surgeon will depend upon completion of my surgery
UofU Patient
August 02, 2022
HUNTSMAN CANCER CENTER
Horrible bedside manner. Spent about 5 mins in the room. Didn't ask me any questions or about my medical history. She was in a rush to get out the door.
UofU Patient
July 24, 2022
HUNTSMAN CANCER CENTER
Absolutely wonderful Doctor!!
UofU Patient
July 19, 2022
HUNTSMAN CANCER CENTER
Absolutely no issues or concerns
UofU Patient
June 20, 2022
HUNTSMAN CANCER CENTER
Fantastic experience
UofU Patient
May 04, 2022
HUNTSMAN CANCER CENTER
My husband and I were so impressed with Dr. Scaife. She explained things so well with pictures and diagrams, and really took the time to explain everything. She was excellent at caring about my concerns and answering all of my questions.
UofU Patient
April 15, 2022
HUNTSMAN CANCER CENTER
Not sure , dr scaife seemed affectively cool , not sure if she was annoyed or what really . she seemed abrupt unlike our first visit where she took all the time to answer my concerns ,
UofU Patient
April 03, 2022
HUNTSMAN CANCER CENTER
Dr. Scaife went over my Cat scan and described everything to me and my wife.
UofU Patient
March 26, 2022
HUNTSMAN CANCER CENTER
It was good.
UofU Patient
March 23, 2022
HUNTSMAN CANCER CENTER
I could not have hoped for a better Doctor. She is very kind and listens to your concerns or needs. Great bedside manners.
UofU Patient
March 21, 2022
HUNTSMAN CANCER CENTER
Dr. Scaife was very clear and concise with the information she provided.
UofU Patient
March 01, 2022
HUNTSMAN CANCER CENTER
I like Dr. Scaiffe. I feel she cared about my pain, comfort and feelings. After having been a surgeon for many years, she still retains her empathy for her patients. I really like her.
UofU Patient
February 27, 2022
HUNTSMAN CANCER CENTER
Excellent
UofU Patient
February 06, 2022
HUNTSMAN CANCER CENTER
It was great to see everyone concerned about me
UofU Patient
February 03, 2022
HUNTSMAN CANCER CENTER
I was very impressed with Dr. Scaife and her staff. She took the time to explain with images of the anatomy pertaining to my condition. It was VERY helpful to have a visual as well as her verbal explanation of my condition.
Dr. Courtney Scaife is a Professor of Surgery at the University of Utah who specializes in the care of patients requiring surgical treatment related to gastrointestinal oncology. Dr. Scaife earned her undergraduate degree from DePauw University and medical degree from the University of Wisconsin. Her general surgery residency was done at the University of Utah which was followed by a two-year fellowship in surgical oncology at the University of Texas MD Anderson Cancer Center. Dr. Scaife joined the faculty at the University of Utah in 2003 and is a tenured academic surgeon. Dr. Scaife’s focus in surgery involves diseases of the liver, pancreas, and gastrointestinal tract. Her clinical efforts include both complex surgical endeavors as well as academic research. She has received numerous research grants and participates with other colleagues in the areas of diagnosis and treatment of cancer, in particular pancreatic cancer.
Dr. Scaife was appointed as the Vice-Chair for Cancer Affairs in Surgery representing the Department of Surgery at the Huntsman Cancer Institute. She is the Chief for the Section of Surgical Oncology in the Division of General Surgery. Additionally, she serves as the Gastrointestinal Disease Center Leader at the Huntsman Cancer Institute.
Academic Locations
Board Certification and Academic Information
| Academic Departments | Surgery
-
Professor |
| Academic Divisions | General Surgery |
Research Interests
- Pancreatic Cancer
- Pancreatic Neoplasms
- Genotype
- Carcinoma, Islet Cell
- Cell Line, Tumor
- Clinical Outcomes
- Stromal Cells
Education History
| Fellowship | University of Texas MD Anderson Cancer Center Oncology Fellow, 2003 |
| Residency | University of Utah School of Medicine General Surgery Resident, 2001 |
| Internship | University of Utah School of Medicine General Surgery Intern, 1996 |
| Professional Medical | University of Wisconsin School of Medicine Medicine M.D., 1995 |
| Undergraduate | DePauw University B.S., 1990 |
Selected Publications - Journal Articles
Journal Article
- Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples AR (2022). Factors associated with changes in exercise behaviors during the COVID-19 pandemic. Cancer Causes Control, 33(7), 939-950.
- Hernandez S, Parra ER, Uraoka N, Tang X, Shen Y, Qiao W, Jiang M, Zhang S, Mino B, Lu W, Pandurengan R, Haymaker C, Affolter K, Scaife CL, Yip-Schneider M, Schmidt CM, Firpo MA, Mulvihill SJ, Koay EJ, Wang H, Wistuba II, Maitra A, Solis LM, Sen S (2021). Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception. Clin Cancer Res, 28(9), 1938-1947.
- Gutnik L, Bleicher J, Davis A, McLeod MC, McCrum M, Scaife C (2022). American Indian/Alaska native access to colorectal cancer screening: Does gastroenterologist density matter? Am J Surg, 224, 965-970.
- Parsons M, Lloyd S, Johnson S, Scaife C, Soares H, Kim R, Kim R, Garrido-Laguna I, Tao R (2022). The Implications of Treatment Delays in Adjuvant Therapy for Resected Cholangiocarcinoma Patients. J Gastrointest Cancer.
- Peoples AR, Oswald LB, Ose J, Daniels B, Himbert C, Hathaway CA, Gigic B, Kirchhoff AC, Lin T, Grossman D, Tward J, Varghese TK Jr, Figueiredo JC, Toriola AT, Beck A, Scaife C, Shibata D, LaStayo P, Gonzalez B, Salas K, Ashworth A, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM (2022). Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions. J Rural Health, 38, 886-899.
- Bleicher J, Fender Z, Johnson JE, Cain BT, Phan K, Powers D, Wei G, Presson AP, Kwok A, Pickron TB, Scaife CL, Huang LC (2021). Use of post-discharge opioid consumption patterns as a tool for evaluating opioid prescribing guidelines. Am J Surg, 224, 58-63.
- Himbert C, Figueiredo JC, Shibata D, Ose J, Lin T, Huang LC, Peoples AR, Scaife CL, Pickron B, Lambert L, Cohan JN, Bronner M, Felder S, Sanchez J, Dessureault S, Coppola D, Hoffman DM, Nasseri YF, Decker RW, Zaghiyan K, Murrell ZA, Hendifar A, Gong J, Firoozmand E, Gangi A, Moore BA, Cologne KG, El-Masry MS, Hinkle N, Monroe J, Mutch M, Bernadt C, Chatterjee D, Sinanan M, Cohen SA, Wallin U, Grady WM, Lampe PD, Reddi D, Krane M, Fichera A, Moonka R, Herpel E, Schirmacher P, Kloor M, von Knebel-Doeberitz M, Nattenmueller J, Kauczor HU, Swanson E, Jedrzkiewicz J, Schmit SL, Gigic B, Ulrich AB, Toriola AT, Siegel EM, Li CI, Ulrich CM, Hardikar S (2021). Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset. Cancers (Basel), 13(15).
- Affolter KE, Hellwig S, Nix DA, Bronner MP, Thomas A, Fuertes CL, Hamil CL, Garrido-Laguna I, Scaife CL, Mulvihill SJ, Underhill HR (2021). Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma. Neoplasia, 23(9), 859-869.
- Bleicher J, Lambert LA, Scaife CL, Colonna A (2021). Current management of malignant bowel obstructions: a survey of acute care surgeons and surgical oncologists. Trauma Surg Acute Care Open, 6(1), e000755.
- Swords DS, Scaife CL (2020). Decompositions of the Contribution of Treatment Disparities to Survival Disparities in Stage I-II Pancreatic Adenocarcinoma. Ann Surg Oncol, 28(6), 3157-3168.
- Swords DS, Scaife CL (2020). ASO Author Reflections: Using Causal Mediation Analysis to Understand the Proportion of Survival Disparities Mediated by Potentially Modifiable Treatment Factors. Ann Surg Oncol, 28(6), 3169-3170.
- Eisele Y, Mallea PM, Gigic B, Stephens WZ, Warby CA, Buhrke K, Lin T, Boehm J, Schrotz-King P, Hardikar S, Huang LC, Pickron TB, Scaife CL, Viskochil R, Koelsch T, Peoples AR, Pletneva MA, Bronner M, Schneider M, Ulrich AB, Swanson EA, Toriola AT, Shibata D, Li CI, Siegel EM, Figueiredo J, Janssen KP, Hauner H, Round J, Ulrich CM, Holowatyj AN, Ose J (2021). Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study. Clin Colorectal Cancer, 20(3), e165-e172.
- Parsons M, Lloyd S, Johnson S, Scaife C, Varghese T, Glasgow R, Garrido-Laguna I, Tao R (2020). Refusal of Local Therapy in Esophageal Cancer and Impact on Overall Survival. Ann Surg Oncol, 28(2), 663-675.
- Bleicher J, Cohan JN, Huang LC, Peche W, Pickron TB, Scaife CL, Bowles TL, Hyngstrom JR, Asare EA (2020). Trends in the management of anorectal melanoma: A multi-institutional retrospective study and review of the world literature. World J Gastroenterol, 27(3), 267-280.
- Swords DS, Mulvihill SJ, Brooke BS, Stoddard GJ, Firpo MA, Scaife CL (2019). County-level Variation in Use of Surgery and Cancer-specific Survival for Stage I-II Pancreatic Adenocarcinoma. Ann Surg, 272(6), 1102-1109.
- Stokes SM, Scaife CL, Brooke BS, Glasgow RE, Mulvihill SJ, Finlayson SRG, Varghese TK Jr (2020). Hospital Costs Following Surgical Complications: A Value-driven Outcomes Analysis of Cost Savings Due to Complication Prevention. Ann Surg, 275, e375-e381.
- Geijsen AJMR, Ulvik A, Gigic B, Kok DE, van Duijnhoven FJB, Holowatyj AN, Brezina S, van Roekel EH, Baierl A, Bergmann MM, Bhm J, Bours MJL, Brenner H, Breukink SO, Bronner MP, Chang-Claude J, de Wilt JHW, Grady WM, Grnberger T, Gumpenberger T, Herpel E, Hoffmeister M, Huang LC, Jedrzkiewicz JD, Keulen ETP, Kiblawi R, Klsch T, Koole JL, Kosma K, Kouwenhoven EA, Kruyt FM, Kvalheim G, Li CI, Lin T, Ose J, Pickron TB, Scaife CL, Schirmacher P, Schneider MA, Schrotz-King P, Singer MC, Swanson ER, van Duijvendijk P, van Halteren HK, van Zutphen M, Vickers K, Vogelaar FJ, Wesselink E, Habermann N, Ulrich AB, Ueland PM, Weijenberg MP, Gsur A, Ulrich CM, Kampman E (2020). Circulating Folate and Folic Acid Concentrations: Associations With Colorectal Cancer Recurrence and Survival. JNCI Cancer Spectr, 4(5), pkaa051.
- Swords DS, Mulvihill SJ, Brooke BS, Firpo MA, Scaife CL (2019). Size and Importance of Socioeconomic Status-Based Disparities in Use of Surgery in Nonadvanced Stage Gastrointestinal Cancers. Ann Surg Oncol, 27(2), 333-341.
- Swords DS, Scaife CL (2019). ASO Author Reflections: Socioeconomic Disparities in Use of Surgery for Gastrointestinal Cancers Are Large and Impactful in Poor-Prognosis Cancers. Ann Surg Oncol, 27(2), 342-343.
- Bleicher J, Shepherd HM, Scaife CL (2020). Hemoglobin A1c as a marker to stratify diabetes risk following pancreaticoduodenectomy. Surg Open Sci, 2(3), 136-139.
- Varedi D, Frigerio A, Scaife C, Hull C (2019). A novel case of TIF1 gamma autoantibody positive dermatomyositis associated with a non-functional pancreatic neuroendocrine tumor. Dermatol Online J, 25(3).
- Shen Y, Zificsak CA, Shea JE, Lao X, Bollt O, Li X, Lisko JG, Theroff JP, Scaife CL, Ator MA, Ruggeri BA, Dorsey BD, Kuwada SK (2015). Design, synthesis, and biological evaluation of sulfonyl acrylonitriles as novel inhibitors of cancer metastasis and spread. J Med Chem, 58(3), 1140-58.
- Russell KW, Scaife CL, Weber DC, Windsor JS, Wheeler AR, Smith WR, Wedmore I, McIntosh SE, Lieberman JR (2014). Wilderness Medical Society practice guidelines for the treatment of acute pain in remote environments: 2014 update. Wilderness Environ Med, 25(4 Suppl), S96-104.
- Bowen ME, Mone MC, Nelson EW, Scaife CL (2014). Image-guided placement of long-term central venous catheters reduces complications and cost. Am J Surg, 208(6), 937-41; discussion 941.
- Chen Y, Youn P, Pysher TJ, Scaife CL, Furgeson DY (2014). Tumour eradication using synchronous thermal ablation and Hsp90 chemotherapy with protein engineered triblock biopolymer-geldanamycin conjugates. Int J Hyperthermia, 30(8), 550-64.
- Martin P, Noonan S, Mullen MP, Scaife C, Tosetto M, Nolan B, Wynne K, Hyland J, Sheahan K, Elia G, ODonoghue D, Fennelly D, OSullivan J (2014). Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer. BMC Cancer, 14, 887.
- Benson AB 3rd, DAngelica MI, Abrams TA, Are C, Bloomston PM, Chang DT, Clary BM, Covey AM, Ensminger WD, Iyer R, Kelley RK, Linehan D, Malafa MP, Meranze SG, Park JO, Pawlik T, Posey JA, Scaife C, Schefter T, Sigurdson ER, Tian GG, Vauthey JN, Venook AP, Yen Y, Zhu AX, Hoffmann KG, McMillian NR, Sundar H (2014). Hepatobiliary cancers, version 2.2014. J Natl Compr Canc Netw, 12(8), 1152-82.
- Kendrick ZW, Firpo MA, Repko RC, Scaife CL, Adler DG, Boucher KM, Mulvihill SJ (2014). Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer. HPB (Oxford), 16(7), 670-6.
- Jackson KL, Glasgow RE, Mone MC, Sheng X, Mulvihill SJ, Scaife CL (2014). Does travel distance influence length of stay in elective pancreatic surgery? HPB (Oxford), 16(6), 543-9.
- Russell KW, Scaife CL, Weber DC, Windsor JS, Wheeler AR, Smith W, Wedmore I, McIntosh SE, Lieberman JR (2014). Wilderness Medical Society practice guidelines for the treatment of acute pain in remote environments. Wilderness Environ Med, 25(1), 41-9.
- Scaife CL, Hewitt KC, Mone MC, Hansen HJ, Nelson ET, Mulvihill SJ (2014). Comparison of intraoperative versus delayed enteral feeding tube placement in patients undergoing a Whipple procedure. HPB (Oxford), 16(1), 62-9.
- Nelson ET, Gross ME, Mone MC, Hansen HJ, Nelson EW, Scaife CL (2013). A survey of American College of Surgery fellows evaluating their use of antibiotic prophylaxis in the placement of subcutaneously implanted central venous access ports. Am J Surg, 206(6), 1034-9; discussion 1039-40.
- Scaife CL, Hartz A, Pappas L, Pelletier P, He T, Glasgow RE, Mulvihill SJ (2013). Association between postoperative complications and clinical cancer outcomes. Ann Surg Oncol, 20(13), 4063-6.
- Russell KW, Mone MC, Scaife CL (2013). Umbilical paracentesis for acute hernia reduction in cirrhotic patients.LID - 10.1136/bcr-2013-201304 [doi]LID - bcr2013201304 [pii]. BMJ Case Rep, 2013.
- Witt BL, Kristen Hilden RN, Scaife C, Chadwick B, Layfield L, Cory Johnston W, Safaee M, Siddiqui A, Adler DG (2013). Identification of factors predictive of malignancy in patients with atypical biliary brushing results obtained via ERCP. Diagn Cytopathol, 41(8), 682-8.
- Poruk KE, Gay DZ, Brown K, Mulvihill JD, Boucher KM, Scaife CL, Firpo MA, Mulvihill SJ (2013). The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr Mol Med, 13(3), 340-51.
- Poruk KE, Firpo MA, Scaife CL, Adler DG, Emerson LL, Boucher KM, Mulvihill SJ (2013). Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma. Pancreas, 42(2), 193-7.
- Jackson KL, Glasgow RE, Hill BR, Mone MC, Sklow B, Scaife CL, Sheng X, Peche WJ (2013). Does travel distance influence length of stay in elective colorectal surgery? Dis Colon Rectum, 56(3), 367-73.
- Rapoport N, Payne A, Dillon C, Shea J, Scaife C, Gupta R (2013). Focused ultrasound-mediated drug delivery to pancreatic cancer in a mouse model. J Ther Ultrasound, 1, 11.
- Chen LL, Chen X, Choi H, Sang H, Chen LC, Zhang H, Gouw L, Andtbacka RH, Chan BK, Rodesch CK, Jimenez A, Cano P, Jones KA, Oyedeji CO, Martins T, Hill HR, Schumacher J, Willmore C, Scaife CL, Ward JH, Morton K, Randall RL, Lazar AJ, Patel S, Trent JC, Frazier ML, Lin P, Jensen P, Benjamin RS (2012). Exploiting antitumor immunity to overcome relapse and improve remission duration. Cancer Immunol Immunother, 61(7), 1113-24.
- Hazard L, Jones K, Shaban A, Anker C, Scaife C, Weis J, Mulvihill S (2012). Prospective phase I study of capecitabine and oxaliplatin concurrent with radiation therapy for the treatment of locally advanced pancreatic adenocarcinoma, and retrospective comparison to concurrent 5-fluorouracil/radiation and gemcitabine/radiation. J Gastrointest Cancer, 43(2), 258-66.
- Pearson EG, Scaife CL, Mulvihill SJ, Glasgow RE (2012). Roux-en-Y drainage of a pancreatic fistula for disconnected pancreatic duct syndrome after acute necrotizing pancreatitis. HPB (Oxford), 14(1), 26-31.
- Gross ME, Nelson ET, Mone MC, Hansen HJ, Sklow B, Glasgow RE, Scaife CL (2011). A comparison of postoperative outcomes utilizing a continuous preperitoneal infusion versus epidural for midline laparotomy. Am J Surg, 202(6), 765-9; discussion 770.
- Rapoport N, Nam KH, Gupta R, Gao Z, Mohan P, Payne A, Todd N, Liu X, Kim T, Shea J, Scaife C, Parker DL, Jeong EK, Kennedy AM (2011). Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J Control Release, 153(1), 4-15.
- Kennedy SA, Scaife C, Dunn MJ, Wood AE, Watson RW (2011). Benefits of heat treatment to the protease packed neutrophil for proteome analysis: halting protein degradation. Proteomics, 11(12), 2560-4.
- Shea JE, Nam KH, Rapoport N, Scaife CL (2011). Genexol inhibits primary tumour growth and metastases in gemcitabine-resistant pancreatic ductal adenocarcinoma. HPB (Oxford), 13(3), 153-7.
- Kopinke D, Brailsford M, Shea JE, Leavitt R, Scaife CL, Murtaugh LC (2011). Lineage tracing reveals the dynamic contribution of Hes1+ cells to the developing and adult pancreas. Development, 138(3), 431-41.
- Scaife CL, Gross ME, Mone MC, Hansen HJ, Litz CL, Nelson ET, Anderson CJ, Wagner G, Gawlick U, Nelson EW (2010). Antibiotic prophylaxis in the placement of totally implanted central venous access ports. Am J Surg, 200(6), 719-22; disussion 722-3.
- Poruk KE, Firpo MA, Huerter LM, Scaife CL, Emerson LL, Boucher KM, Jones KA, Mulvihill SJ (2010). Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev, 19(10), 2605-10.
- Scaife CL, Shea J, Emerson L, Boucher K, Firpo MA, Beckerle MC, Mulvihill SJ (2010). Prognostic significance of PINCH signalling in human pancreatic ductal adenocarcinoma. HPB (Oxford), 12(5), 352-8.
- Deer EL, Gonzlez-Hernndez J, Coursen JD, Shea JE, Ngatia J, Scaife CL, Firpo MA, Mulvihill SJ (2010). Phenotype and genotype of pancreatic cancer cell lines. Pancreas, 39(4), 425-35.
- Rapoport N, Kennedy AM, Shea JE, Scaife CL, Nam KH (2010). Ultrasonic nanotherapy of pancreatic cancer: lessons from ultrasound imaging. Mol Pharm, 7(1), 22-31.
Editorial
- Swords DS, Scaife CL (2021). Granular neighborhood-level socioeconomic data: An opportunity for a different kind of precision oncology? Am J Surg, 222(1), 8-9.
- Scaife C (2019). SWSC 2019 Presidential address "Putting Patients First". Am J Surg, 218(6), 1035-1039.
Other
- Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples AR (2021). Impact of the COVID-19 pandemic on exercise habits among cancer patients. United States.
- Tempero MA, Malafa MP, Al-Hawary M, Behrman SW, Benson AB, Cardin DB, Chiorean EG, Chung V, Czito B, Del Chiaro M, Dillhoff M, Donahue TR, Dotan E, Ferrone CR, Fountzilas C, Hardacre J, Hawkins WG, Klute K, Ko AH, Kunstman JW, LoConte N, Lowy AM, Moravek C, Nakakura EK, Narang AK, Obando J, Polanco PM, Reddy S, Reyngold M, Scaife C, Shen J, Vollmer C, Wolff RA, Wolpin BM, Lynn B, George GV (2021). Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (19(4), pp. 439-457). United States.
- Kinsey CG, Camolotto SA, Boespflug AM, Guillen KP, Foth M, Truong A, Schuman SS, Shea JE, Seipp MT, Yap JT, Burrell LD, Lum DH, Whisenant JR, Gilcrease GW 3rd, Cavalieri CC, Rehbein KM, Cutler SL, Affolter KE, Welm AL, Welm BE, Scaife CL, Snyder EL, McMahon M (2019). Publisher Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nat Med (25(5), p. 861). United States.
The Scope & Other Podcasts
- Overwhelmed with Information on Colorectal Cancer Treatment? Talk to Your Doctor
- Do You Need a Whipple Procedure? All About the Surgery and Life Afterward
- Do You Need Surgery for Barrett’s Esophagus?
- Pancreas Cancer - The Tumor Stroma Interaction - Courtney Scaife, MD and Jill Shea, MD - 11/16/11
- Courtney Scaife